相关实验视频

Updated: May 7, 2025

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

针对复杂的胰腺瘤微环境的挑战和机会

Jennifer M Finan^1,2, Yifei Guo^1,2, Shaun M Goodyear³

¹Department of Surgery, Oregon Health & Science University, Portland, OR.

JCO oncology advances

|December 30, 2024

概括

胰腺癌 (PDAC) 治疗因其密的瘤微环境 (TME) 而扎. 用组合疗法和分子分层来准TME异质性可能会改善患者的治疗结果.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
瘤微环境研究研究

背景情况:

胰腺管腺癌 (PDAC) 的5年生存率很低 (13%) 和治疗疗效有限.
密的肌层和异质的瘤微环境 (TME) 导致对化疗和免疫疗法的反应不佳.
目前针对PDAC流体或免疫反应的治疗方法在临床上取得了有限的成功.

研究的目的:

审查PDAC瘤微环境 (TME) 的异质元素.
讨论针对TME异质性的组合疗法的潜力.
探索分子分层化如何增强治疗反应.

主要方法:

关于PDAC瘤微环境 (TME) 组件的文献综述.
对针对TME的现有和新兴治疗策略的分析.
讨论组合疗法方法和分子分层.

主要成果:

PDAC TME的特点是显著的异质性.
针对TME的临床前策略显示出希望,但在临床转化中经常失败.
建议使用组合疗法和分子分层方法来克服治疗耐药性.

结论:

针对异质的PDAC TME是提高治疗疗效的关键.
根据个体TME形状量身定制的组合疗法具有显著的潜力.
分子分层可能会优化针对性和组合治疗的患者选择.

更多相关视频

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis

Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis

Published on: June 22, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...